本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

77.64
-0.5900-0.75%
盤前78.320.6797+0.88%04:05 EDT
成交量:65.88萬
成交額:5,157.82萬
市值:34.07億
市盈率:-71.73
高:79.75
開:78.38
低:77.08
收:78.23
52周最高:91.53
52周最低:50.71
股本:4,388.30萬
流通股本:3,563.83萬
量比:1.19
換手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:9.83
市盈率(LYR):-48.83

資料載入中...

2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]